>
#675: The Principle of Self-Ownership | James Corbett
DEAR MR. PRESIDENT - Let Cattleman SELL BEEF, not just Cattle.
War On Terror? Trump Pulls Syrian Al-Qaeda From US Terror List
The copper market is facing a severe supply squeeze
Singapore is experimenting with biological computing using living human neurons...
It's Happening - Europe is Building an Impossible Fusion Reactor
Portable 1MW Kaleidos Microreactor Secures Critical Nuclear Fuel Deal Through 2030s
This New All-In-One Range Extender Is Ready To Go Into Any Electric Truck
Aptera Reveals The Secret To Building Its Solar EV: China
High-voltage sodium home battery emerges as affordable rooftop solar solution
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance...
China has released Origin Pilot, claimed to be the world's first open-source operating system...
ShieldAI XBAT Drone Fighters Can Give A Fighter Drone Wing to Every US Destroyer
Brain organoids, kept alive more than five years, matured like human brains

Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.